JP2018514589A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514589A5
JP2018514589A5 JP2018507796A JP2018507796A JP2018514589A5 JP 2018514589 A5 JP2018514589 A5 JP 2018514589A5 JP 2018507796 A JP2018507796 A JP 2018507796A JP 2018507796 A JP2018507796 A JP 2018507796A JP 2018514589 A5 JP2018514589 A5 JP 2018514589A5
Authority
JP
Japan
Prior art keywords
salt
pharmaceutical composition
cannabinoid
thc
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018507796A
Other languages
English (en)
Japanese (ja)
Other versions
JP6938465B2 (ja
JP2018514589A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2016/050414 external-priority patent/WO2016174661A1/en
Publication of JP2018514589A publication Critical patent/JP2018514589A/ja
Publication of JP2018514589A5 publication Critical patent/JP2018514589A5/ja
Priority to JP2021057991A priority Critical patent/JP2021107401A/ja
Application granted granted Critical
Publication of JP6938465B2 publication Critical patent/JP6938465B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018507796A 2015-04-29 2016-04-19 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ Active JP6938465B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021057991A JP2021107401A (ja) 2015-04-29 2021-03-30 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562154144P 2015-04-29 2015-04-29
US62/154,144 2015-04-29
PCT/IL2016/050414 WO2016174661A1 (en) 2015-04-29 2016-04-19 Combinations of cannabinoids and n-acylethanolamines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021057991A Division JP2021107401A (ja) 2015-04-29 2021-03-30 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ

Publications (3)

Publication Number Publication Date
JP2018514589A JP2018514589A (ja) 2018-06-07
JP2018514589A5 true JP2018514589A5 (enExample) 2019-05-30
JP6938465B2 JP6938465B2 (ja) 2021-09-22

Family

ID=57199061

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018507796A Active JP6938465B2 (ja) 2015-04-29 2016-04-19 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ
JP2021057991A Pending JP2021107401A (ja) 2015-04-29 2021-03-30 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021057991A Pending JP2021107401A (ja) 2015-04-29 2021-03-30 カンナビノイドとｎ−アシルエタノールアミンの組み合わせ

Country Status (12)

Country Link
US (7) US11234956B2 (enExample)
EP (2) EP4193993A3 (enExample)
JP (2) JP6938465B2 (enExample)
CN (2) CN107530317A (enExample)
AU (4) AU2016254685B2 (enExample)
CA (1) CA2984088C (enExample)
DK (1) DK3288553T3 (enExample)
ES (1) ES2935605T3 (enExample)
IL (2) IL291864A (enExample)
MA (1) MA41997A (enExample)
PL (1) PL3288553T3 (enExample)
WO (1) WO2016174661A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4193993A3 (en) * 2015-04-29 2023-07-19 Scisparc Ltd. Combinations of cannabinoids and n-acylethanolamines
WO2019136351A1 (en) * 2018-01-05 2019-07-11 Altus Labs, Llc Personal care compositions
EP3746068A4 (en) * 2018-01-29 2021-11-03 Evero COMPOSITIONS AND METHODS OF TREATMENT FOR OBSTRUCTIVE SLEEP APNEA
US11951086B2 (en) * 2018-04-03 2024-04-09 Pure Green Pharmaceuticals, Inc. Tablet or composition having n-acyl ethanolamine and cannabinoid
WO2020160452A1 (en) * 2019-02-01 2020-08-06 Tess Ventures, Inc. Combining serms, sarms, and cannabinoids for improving safety and efficacy of endocrine therapies
AU2020260090C9 (en) 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use
EP3958850A4 (en) * 2019-04-23 2023-04-26 Scisparc Ltd. COMPOSITIONS AND METHODS FOR ENHANCEMENT OF 4-AMINOPHENOLS DERIVATIVES
EP3965789A4 (en) * 2019-05-07 2023-01-25 Ojai Energetics PBC PROCEDURE FOR OPTIMIZING CANNABINOID DOSAGE DETERMINATION
CA3139288A1 (en) 2019-05-23 2020-11-26 Ramachandra MUKUNDA Compositions and methods using cannabinoids for treating stammering/stutering and symptoms of tourette syndrome
EP4017486A4 (en) * 2019-08-19 2023-09-20 Buzzelet Development And Technologies Ltd COMPOSITIONS FOR TREATING A CONDITION CHARACTERIZED BY ANANDAMID DEFICIENCY AND USES THEREOF
EP3838346A1 (en) * 2019-12-20 2021-06-23 Chemo Research SL Soft gelatin capsules comprising palmitoylethanolamide and alpha-lipoic acid
US20230080593A1 (en) 2020-01-10 2023-03-16 Pacira Pharmaceuticals, Inc. Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
CN115515581A (zh) 2020-01-10 2022-12-23 帕西拉制药股份有限公司 通过给予缓释脂质体麻醉组合物治疗疼痛
US11273122B2 (en) 2020-02-11 2022-03-15 Therese Mainella Combination of cannabis, derivatives thereof and additives in oral care compositions
EP4274573A4 (en) * 2021-01-11 2024-12-11 Pacira Pharmaceuticals, Inc. TREATMENT OF HIP PAIN WITH LIPOSOMAL SUSTAINED-RELEASE ANESTHESIA COMPOSITIONS
US20230000936A1 (en) * 2021-06-30 2023-01-05 Demetrix, Inc. Alleviation of itching sensations using cannabinoid compounds
WO2023039419A2 (en) 2021-09-08 2023-03-16 Plantible Foods Inc. Systems and methods for measuring mat density of aquatic biomass
JP2025512495A (ja) 2022-04-12 2025-04-17 シャッケルフォード・ファーマ・インコーポレーテッド 発作性障害の治療
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
US12226610B2 (en) 2022-11-03 2025-02-18 Pacira Pharmaceuticals, Inc. Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
WO2024124354A1 (en) * 2022-12-16 2024-06-20 Aima Inc. Compositions and methods for treating or preventing pain or other disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942317D1 (de) * 1998-05-29 2010-06-10 Neurosciences Res Found Schmerzlinderung mit anandamide
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
GB2394894B (en) * 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
WO2007006319A2 (en) 2005-07-14 2007-01-18 Rheoscience A/S Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders
GB2432312A (en) * 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
EP2796129B1 (en) * 2009-09-07 2015-06-17 Epitech Group S.r.l. Composition containing ultra - micronized palmitoyl - ethanolamide
AT509000B1 (de) * 2009-10-23 2012-12-15 Rausch Peter Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
GB2495118B (en) * 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
EP2719375A1 (en) * 2012-10-10 2014-04-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms
EP4193993A3 (en) * 2015-04-29 2023-07-19 Scisparc Ltd. Combinations of cannabinoids and n-acylethanolamines

Similar Documents

Publication Publication Date Title
ES2542868T3 (es) Terapia de combinación para el tratamiento de diabetes asociada con la obesidad
EP3288553B1 (en) Combinations of cannabinoids and n-acylethanolamines
ES2988617T3 (es) Norketotifeno para el tratamiento de la hipercitocinemia y las infecciones virales
EP3236960B1 (en) Fluralaner for use in the treatment of demodicosis
AU2016201325B2 (en) Methods Of Providing Weight Loss Therapy In Patients With Major Depression
CA2973698A1 (en) Compositions and methods for inhibiting fungal infections
CN117177743A (zh) 包含依维莫司和安森司群的组合
KR20250079059A (ko) 모발 성장 자극을 위한 알파-케토부티레이트, 알파-케토글루타레이트, 및 2-하이드록시부티레이트
AU2019299213A1 (en) Cannabidiol combination compositions
US20260102374A1 (en) Methods of treating bacterial infections
WO2021207325A1 (en) Natural extract and their components for use in mitigating acute respiratory distress syndrome
JP2014533692A (ja) 虚血による神経細胞障害を低減するためのアポエクオリン
EA022711B1 (ru) Комбинация дибромида 1,12-додекаметилен-бис-[4-метил-5-(2-гидроксиэтил)тиазолия] и артесуната для лечения тяжелой формы малярии
EP4236931B1 (en) Compositions comprising tetrahydrocannabinol for treating acute respiratory failure and/or acute respiratory distress syndrome
CN116549455A (zh) PLK4抑制剂Centrinone在制备治疗包虫病药物中的应用
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
US20060211672A1 (en) Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis
CN110693903B (zh) 一种治疗急性单核细胞白血病的药物及三氧化二砷和双氢青蒿素的应用
KR20220111620A (ko) 코비드-19 감염증의 예방 또는 치료용 약제학적 조성물
US20230263812A1 (en) Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same
AU726664B2 (en) Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
CN112641765B (zh) 丙泊酚的抗疲劳制药用途
EP4098254A1 (en) Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease
US20060128738A1 (en) Treatment of interstitial cystitis using cannabinoid analogs
US20070093519A1 (en) Anti-emetic uses of cannabinoid analogs